Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Healthcare Value Capital, LLC (CIK 1458461) reported $50.7M across 16 reported positions in its SEC 13F filing for 2021-09-30. Largest positions: ALKS ($6.2M, 12.18%), PFE ($5.4M, 10.62%), GILD ($4.2M, 8.27%), GSK ($3.8M, 7.54%), AMYT ($3.0M, 5.97%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | ALKS | ALKERMES PLC | $6.2M | 12.18% | 200,000 | Added |
| 2 | PFE | PFIZER INC | $5.4M | 10.62% | 125,000 | Added |
| 3 | GILD | GILEAD SCIENCES INC | $4.2M | 8.27% | 60,000 | Trimmed |
| 4 | GSK | GLAXOSMITHKLINE PLC | $3.8M | 7.54% | 100,000 | Hold |
| 5 | AMYT | AMRYT PHARMA PLC | $3.0M | 5.97% | 250,000 | Added |
| 6 | AZN | ASTRAZENECA PLC | $3.0M | 5.93% | 50,000 | Hold |
| 7 | MRK | MERCK & CO INC | $3.0M | 5.93% | 40,000 | Hold |
| 8 | BMY | BRISTOL-MYERS SQUIBB CO | $3.0M | 5.84% | 50,000 | Hold |
| 9 | SPXU | PROSHARES TR | $2.6M | 5.19% | 150,000 | Added |
| 10 | IRWD | IRONWOOD PHARMACEUTICALS INC | $2.6M | 5.16% | 200,000 | Trimmed |
| 11 | CLVS | CLOVIS ONCOLOGY INC | $2.2M | 4.40% | 500,000 | Hold |
| 12 | TYME | TYME TECHNOLOGIES INC | $2.1M | 4.07% | 2.0M | Added |
| 13 | ATRS | ANTARES PHARMA INC | $1.8M | 3.59% | 500,000 | Hold |
| 14 | SQQQ | PROSHARES TR | $1.7M | 3.41% | 200,000 | Added |
| 15 | UVXY | PROSHARES TR II | $1.2M | 2.42% | 50,000 | New |
| 16 | AMRN | AMARIN CORP PLC | $1.0M | 2.01% | 200,000 | Hold |
| 17 | VRTX | VERTEX PHARMACEUTICALS INC | $907,000 | 1.79% | 5,000 | New |
| 18 | GNLN | GREENLANE HLDGS INC | $830,000 | 1.64% | 350,000 | Hold |
| 19 | VYNE | VYNE THERAPEUTICS INC | $556,000 | 1.10% | 400,000 | Trimmed |
| 20 | ADMS | ADAMAS PHARMACEUTICALS INC | $491,000 | 0.97% | 100,000 | Hold |
| 21 | GMDAQ | GAMIDA CELL LTD | $392,000 | 0.77% | 100,000 | Added |
| 22 | DRRX | DURECT CORP | $320,000 | 0.63% | 250,000 | New |
| 23 | VIXY | PROSHARES TR II | $285,000 | 0.56% | 12,500 | Trimmed |
| 24 | MDXG | MIMEDX GROUP INC | $0 | 0.00% | 0 | Exited |
| 25 | COLL | COLLEGIUM PHARMACEUTICAL INC | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2021-09-30